Tanyüksel, MehmetBaş, Ahmet LeventAraz, EnginÖzyurt, MustafaAlbay, AliBabür, Cahit2020-03-262020-03-2620051300-0128https://hdl.handle.net/20.500.12395/19768Toxoplasmosis is a common problem, accounting for significant morbidity in developing countries. Conventional treatments are associated with frequent relapses and with additional problems including undesirable side effects. Better-tolerated and more effective drugs are clearly needed. The aim of this study is to evaluate the in vitro efficacy of azithromycin and roxithromycin against Toxoplasma gondii using acridine orange in the fluorescence microscopic assay. It was found that azithromycin and roxithromycin had significant microbicidal activity (P < 0.05). In conclusion, this observation should be assessed carefully in future clinical trials involving a large number of cases with toxoplasmosis.eninfo:eu-repo/semantics/openAccessToxoplasma gondiiazithromycinroxithromycinin vitro efficacyArticle292525529Q3WOS:000229422000050Q4